Agios Pharmaceuticals
AGIO
#4938
Rank
โ‚ฌ1.47 B
Marketcap
25,11ย โ‚ฌ
Share price
3.55%
Change (1 day)
-14.61%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: โ‚ฌ1.47 Billion

As of March 2026 Agios Pharmaceuticals has a market cap of โ‚ฌ1.47 Billion. This makes Agios Pharmaceuticals the world's 4938th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.47 B5.76%
2025โ‚ฌ1.39 B-24.01%
2024โ‚ฌ1.83 B62.57%
2023โ‚ฌ1.12 B-21.72%
2022โ‚ฌ1.43 B-8.75%
2021โ‚ฌ1.57 B-35.4%
2020โ‚ฌ2.43 B-16.32%
2019โ‚ฌ2.91 B24.25%
2018โ‚ฌ2.34 B1.01%
2017โ‚ฌ2.32 B39.37%
2016โ‚ฌ1.66 B-25.53%
2015โ‚ฌ2.23 B-34.51%
2014โ‚ฌ3.41 B531.61%
2013โ‚ฌ0.54 B

End of Day market cap according to different sources

On Mar 16th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

โ‚ฌ1.47 Billion
by Nasdaq info icon info icon
โ‚ฌ1.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ131.71 B 8,854.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ770.63 B 52,289.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ93.85 B 6,280.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
โ‚ฌ0.76 B-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚ฌ9.58 B 551.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.61 B 553.64%๐Ÿ‡บ๐Ÿ‡ธ USA